Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 513 clinical trials
  • 0 views
  • 13 Aug, 2024
Comparison of Symptoms, Pulmonary Function, Muscle Strength, Exercise Capacity, and Frailty Level in Individuals With Esophageal Atresia and Healthy Individuals

This study aims to compare physical characteristics, body composition, pulmonary function and muscle strength, peak cough flow, posture assessment, peripheral muscle strength test, motor function, exercise capacity, physical activity level, fatigue, frailty and quality of life between children with esophageal atresia and their healthy peers.

Accepts healthy volunteers
Online studies
  • 0 views
  • 19 May, 2025
  • Online study
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients

To evaluate the pharmacokinetics (PK) of venglustat in Autosomal Dominant Polycystic Kidney Disease patients (Stages 1 and 2). To determine the effect of venglustat on pain and fatigue, based on patient reported diary (Stages 1 and 2). Safety/tolerability objective: To characterize the safety profile of venglustat (Stages 1 and 2).

cyst
polycystic kidney disease
cystic renal diseases
tolvaptan
renal disease
  • 0 views
  • 04 Dec, 2020
  • 81 locations
Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) (phaethuSA)

Primary Objective: To evaluate the therapeutic efficacy of one dose level of SAR441344 versus placebo over 12 weeks in adult patients with primary Sjögren's syndrome (pSjS), assessed by the change of the European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease Activity Index (ESSDAI) Secondary Objectives: To evaluate the therapeutic efficacy …

  • 0 views
  • 17 Nov, 2021
  • 28 locations
  • None views
  • None views
  • None views
  • None views
  • None views
  • None views